Development and validation of a GC-FID method for quantitation of impurities in kemantane drug substance

The objective of the study was to develop and validate a new GC-FID method for determination of impurities in kemantane (5-hydroxyadamantan-2-one) drug substance. The chromatographic mobilities of potential impurities in kemantane such as adamantan-2-one, adamantan-1-ol, adamantan-2-ol, adamantane-1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical chemistry journal 2013-09, Vol.47 (6), p.330-336
Hauptverfasser: Tolkacheva, A. V., Grushevskaya, L. N., Avdyunina, N. I., Pyatin, B. M., Prokofeva, V. I., Gaevaya, L. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The objective of the study was to develop and validate a new GC-FID method for determination of impurities in kemantane (5-hydroxyadamantan-2-one) drug substance. The chromatographic mobilities of potential impurities in kemantane such as adamantan-2-one, adamantan-1-ol, adamantan-2-ol, adamantane-1,4-diol, adamantane-1,4-diol ( syn -isomer), adamantane-2,6-diol, and adamantane-2,6-dione were studied. The chromatographic separation was performed on a quartz capillary column (VF-624ms, 60 m × 0.32 mm, 1.80 μm film thickness). The chromatographic system suitability parameters and method robustness factor were determined. The method had acceptable specificity, accuracy, linearity, and precision and high sensitivity. The developed method detected an impurity of adamantane-2,6-dione from 1.01 to 2.97% in four batches of kemantane drug substance.
ISSN:0091-150X
1573-9031
DOI:10.1007/s11094-013-0955-9